| Symbol | EMISR |
|---|---|
| Name | EMMIS ACQUISITION CORP. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 515 E LAS OLAS BLVD SUITE 120, FORT LAUDERDALE, 33301, United States |
| Telephone | 954-294-6285 |
| Fax | — |
| — | |
| Website | https://emmisacquisition.com/ |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0002075816 |
| Description |
No news found.
No clinical trials found for this company.
No clinical products found for this company.